1910 Genetics and Microsoft partner to enhance pharmaceutical R&D

1910 Genetics has entered an agreement with Microsoft, aiming to revitalise pharmaceutical research and development (R&D) productivity.

Related Posts

FDA calls for treatments for meth and cocaine addiction

Oct 4, 2023

Takeda’s ADZYNMA gains EU approval for cTTP treatment

Aug 9, 2024

STAT+: Up and down the ladder: The latest comings and g...

Mar 19, 2023